熱門資訊> 正文

Terns Pharmaceutical股价为每股40美元

2025-12-10 15:20

Terns Pharmaceuticals, Inc.(TERN) 0

Terns Pharmaceuticals (TERN) priced an upsized underwritten public offering of 16.25M shares at a public offering price of $40.00 per share.
The gross proceeds from the offering are expected to be $650M.
The underwriters have a 30-day option to purchase up to an additional ~2.44M shares.
The offering is expected to close on December 11, 2025.
The stock price traded ~1.2% higher on Tuesday during after-hours trading.

More on Terns Pharmaceuticals

Terns Pharmaceuticals: CML Data Blows Wall Street Away - Again
Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia Transcript
Terns Pharmaceuticals: GLP-1 Obesity Drug Cut Warrants Downgrade To 'Hold' Rating
Terns Pharmaceuticals proposes $400M equity offering
Terns Pharmaceuticals GAAP EPS of -$0.27

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。